Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.7380
+0.03805.43%
Post-market: 0.7301-0.0079-1.07%19:59 EDT
Volume:533.97K
Turnover:410.75K
Market Cap:33.04M
PE:-0.95
High:0.8500
Open:0.6800
Low:0.6800
Close:0.7000
52wk High:1.87
52wk Low:0.5011
Shares:44.77M
Float Shares:21.52M
Volume Ratio:1.06
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-2.08
PE(LYR):-0.89

Loading ...

Company Profile

Company Name:
TELA Bio, Inc.
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
218
Office Location:
1 Great Valley Parkway,Suite 24,Malvern,Pennsylvania,United States
Zip Code:
19355
Fax:
- -
Introduction:
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Directors

Name
Position

Shareholders

Name
Position
Heather Getz
Principal Financial Officer